Literature DB >> 23821042

Genetic services and testing in the Sultanate of Oman. Sultanate of Oman steps into modern genetics.

Anna Rajab1, I Al Rashdi, Q Al Salmi.   

Abstract

The Sultanate of Oman is a rapidly developing Muslim country with well-organised government-funded health care services, including primary, secondary and tertiary, and rapidly expanding medical genetic facilities. At the present time, the Omani population is characterised by a rapid rate of growth, large family size, consanguineous marriages, and the presence of genetic isolates. The preservation of a tribal structure in the community coupled with traditional isolation has produced unique and favourable circumstances for building genealogical records and the study of genetic disease. Genetic services developed in the Sultanate of Oman in the past decade have become an important component of health care. The recently constructed Genetic Centre in Muscat expects to meet the needs of the Omani population in provision of genetic services and research, in a manner deferential to the cultural and religious traditions of the country.

Entities:  

Year:  2013        PMID: 23821042      PMCID: PMC3739849          DOI: 10.1007/s12687-013-0153-1

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  22 in total

1.  A study of consanguinity in the Sultanate of Oman.

Authors:  A Rajab; M A Patton
Journal:  Ann Hum Biol       Date:  2000 May-Jun       Impact factor: 1.533

2.  Pattern of inborn errors of metabolism in an Omani population of the Arabian Peninsula.

Authors:  S N Joshi; J Hashim; P Venugopalan
Journal:  Ann Trop Paediatr       Date:  2002-03

Review 3.  Consanguineous marriage and childhood health.

Authors:  A H Bittles
Journal:  Dev Med Child Neurol       Date:  2003-08       Impact factor: 5.449

4.  The Gulf Cooperation Countries genetic services. Understanding individuals, families, and community needs.

Authors:  Anna A Rajab; Mohsen Af El-Hazmi
Journal:  Saudi Med J       Date:  2007-09       Impact factor: 1.484

5.  Spectrum of beta-thalassemia mutations in Oman.

Authors:  S Daar; H M Hussein; T Merghoub; R Krishnamoorthy
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

6.  Major factors determining the frequencies of hemoglobinopathies in Oman.

Authors:  A Rajab; M A Patton
Journal:  Am J Med Genet       Date:  1997-08-08

7.  Frequency and clinical significance of erythrocyte genetic abnormalities in Omanis.

Authors:  J M White; B S Christie; D Nam; S Daar; D R Higgs
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

8.  Molecular characterization of G6PD deficiency in Oman.

Authors:  S Daar; T J Vulliamy; J Kaeda; P J Mason; L Luzzatto
Journal:  Hum Hered       Date:  1996 May-Jun       Impact factor: 0.444

9.  The frequency of posterior urethral valves in Oman.

Authors:  A Rajab; N V Freeman; M Patton
Journal:  Br J Urol       Date:  1996-06

10.  Neural tube defects and congenital hydrocephalus in the Sultanate of Oman.

Authors:  A Rajab; A Vaishnav; N V Freeman; M A Patton
Journal:  J Trop Pediatr       Date:  1998-10       Impact factor: 1.165

View more
  11 in total

1.  Insight into Ocular Genetic Research: 
Trends in Oman.

Authors:  Rayhanah Al-Mjeni
Journal:  Oman Med J       Date:  2015-05

2.  Congenital and genetic disorders in the Sultanate of Oman. First attempt to assess healthcare needs.

Authors:  A Rajab; Q Al Salmi; J Jaffer; A J Mohammed; M A Patton
Journal:  J Community Genet       Date:  2014-03-02

Review 3.  Existing challenges associated with offering prenatal genetic diagnosis in an Arab society in the Sultanate of Oman.

Authors:  Zandrè Bruwer; Udayakumar Achandira; Khalsa Al Kharousi; Adila Al-Kindy
Journal:  J Genet Couns       Date:  2014-09-19       Impact factor: 2.537

4.  Repository of mutations from Oman: The entry point to a national mutation database.

Authors:  Anna Rajab; Nishath Hamza; Salma Al Harasi; Fatma Al Lawati; Una Gibbons; Intesar Al Alawi; Karoline Kobus; Suha Hassan; Ghariba Mahir; Qasim Al Salmi; Barend Mons; Peter Robinson
Journal:  F1000Res       Date:  2015-09-23

Review 5.  The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry disease.

Authors:  Dominique P Germain; Sergey Moiseev; Fernando Suárez-Obando; Faisal Al Ismaili; Huda Al Khawaja; Gheona Altarescu; Fellype C Barreto; Farid Haddoum; Fatemeh Hadipour; Irina Maksimova; Mirelle Kramis; Sheela Nampoothiri; Khanh Ngoc Nguyen; Dau-Ming Niu; Juan Politei; Long-Sun Ro; Dung Vu Chi; Nan Chen; Sergey Kutsev
Journal:  Mol Genet Genomic Med       Date:  2021-04-09       Impact factor: 2.183

6.  End-Stage Kidney Failure in Oman: An Analysis of Registry Data with an Emphasis on Congenital and Inherited Renal Diseases.

Authors:  Intisar Al Alawi; Issa Al Salmi; Adhra Al Mawali; Yacoub Al Maimani; John A Sayer
Journal:  Int J Nephrol       Date:  2017-06-08

Review 7.  Health-Related Quality of Life of Children and Adolescents with Sickle Cell Disease in the Middle East and North Africa Region: A systematic review.

Authors:  Suthan Pandarakutty; Kamala Murali; Judie Arulappan; Sulaiman D Al Sabei
Journal:  Sultan Qaboos Univ Med J       Date:  2020-12-21

8.  Factors Affecting the Willingness to Undertake Premarital Screening Test Among Prospective Marital Individuals.

Authors:  Ali Alkalbani; Maryam Alharrasi; Susan Achura; Ammar Al Badi; Amjad Al Rumhi; Khalid Alqassabi; Raya Almamari; Omar Alomari
Journal:  SAGE Open Nurs       Date:  2022-02-25

9.  Clinical and genetic characteristics of autosomal recessive polycystic kidney disease in Oman.

Authors:  Intisar Al Alawi; Elisa Molinari; Issa Al Salmi; Fatma Al Rahbi; Adhra Al Mawali; John A Sayer
Journal:  BMC Nephrol       Date:  2020-08-14       Impact factor: 2.388

10.  Effectiveness of Nurse Led Intervention on Health Related Quality of Life among Children with Sickle Cell Disease in Oman: A Pilot Study.

Authors:  Suthan Pandarakutty; Kamala Murali; Judie Arulappan; Deepa Shaji Thomas
Journal:  Adv Hematol       Date:  2019-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.